GWAS, replication and meta-analysis results for loci reaching P < 10−6 in the discovery GWAS
Discovery stage . | Replication . | Meta-analysis . | Meta-analysis with DKD adjustmenta . | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNP . | Chr:Pos_REF/ALT . | Gene . | EAF . | OR (95% CI) . | P-value . | RSQ . | N . | Power . | P-value . | Dir . | OR (95% CI) . | P-value . | OR (95% CI) . | P-value . |
rs1970112 | 9:22085598_T/C | CDKN2B-AS1 | 0.41 | 1.32 (1.2–1.46) | 1.50 × 10−8 | 0.98 | 434/3123 | 0.46 | 0.09 | + +++ | 1.27 (1.17–1.38) | 1.19 × 10−8 | 1.28 (1.18–1.39) | 1.91 × 10−9 |
rs181176493 | 2:224157866_G/A | TRK-TTT15-1(pseudo)*, KCNE4† | 0.01 | 3.88 (2.33–6.47) | 1.98 × 10−7 | 0.80 | – | – | – | + ??? | 3.88 (2.33–6.47) | 1.98 × 10−7 | 3.62 (2.19–5.98) | 4.91 × 10−7 |
rs70962766 | 2:62406999_ CTTTTTTTTTTTT/C | RPSA26(pseudo)*, B3GNT2* | 0.99 | 0.2 (0.11–0.37) | 4.68 × 10−7 | 0.64 | – | – | – | − ??? | 0.2 (0.11–0.37) | 4.68 × 10−7 | 0.47 (0.29–0.75) | 0.0017 |
rs138181578 | 6:45725830_A/AT | LOC107986519†, CLIC5† | 0.99 | 0.18 (0.09–0.35) | 6.78 × 10−7 | 0.77 | – | – | – | − ??? | 0.18 (0.09–0.35) | 6.78 × 10−7 | 0.36 (0.22–0.60) | 8.33 × 10−5 |
rs10625784 | 11:106193897_T/TAAA | LOC643855*, AASDHPPT† | 0.99 | 0.23 (0.13–0.42) | 7.63 × 10−7 | 0.83 | – | – | – | − ??? | 0.23 (0.13–0.42) | 7.63 × 10−7 | 0.44 (0.28–0.70) | 0.00045 |
rs79237700 | 15:53741612_T/C | LOC105370826, WDR72* | 0.04 | 1.97 (1.51–2.55) | 3.86 × 10−7 | 0.75 | 237/632 | 0.17 | 0.79 | + −?? | 1.82 (1.42–2.33) | 2.23 × 10−6 | 1.76 (1.37–2.25) | 6.88 × 10−6 |
rs574480779 | 5:154390880_TA/T | KIF4B | 0.03 | 2.27 (1.64–3.15) | 9.36 × 10−7 | 0.69 | – | – | – | + ??? | 2.27 (1.64–3.15) | 9.36 × 10−7 | 2.14 (1.56–2.95) | 2.91 × 10−6 |
rs1344228 | 2:124286924_C/T | LOC100422580†, CNTNAP5‡ | 0.11 | 1.46 (1.26–1.69) | 5.64 × 10−7 | 1.00 | 434/3123 | 0.33 | 0.71 | + −++ | 1.33 (1.17–1.51) | 8.68 × 10−6 | 1.33 (1.17–1.50) | 8.30 × 10−6 |
rs6055069 | 20:134284_T/C | DEFB127 | 0.98 | 0.24 (0.15–0.38) | 2.35 × 10−9 | 0.62 | 322/1917 | 0.95 | 0.74 | − +?− | 0.38 (0.25–0.56) | 1.36 × 10−6 | 0.49 (0.35–0.70) | 9.80 × 10−5 |
rs2112481 | 5:125691632_T/G | GRAMD2B | 0.99 | 0.10 (0.04–0.23) | 6.98 × 10−8 | 0.63 | 434/3123 | 1 | 0.35 | − +−+ | 0.67 (0.43–1.01) | 0.058 | 0.73 (0.50–1.06) | 0.097 |
Discovery stage . | Replication . | Meta-analysis . | Meta-analysis with DKD adjustmenta . | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNP . | Chr:Pos_REF/ALT . | Gene . | EAF . | OR (95% CI) . | P-value . | RSQ . | N . | Power . | P-value . | Dir . | OR (95% CI) . | P-value . | OR (95% CI) . | P-value . |
rs1970112 | 9:22085598_T/C | CDKN2B-AS1 | 0.41 | 1.32 (1.2–1.46) | 1.50 × 10−8 | 0.98 | 434/3123 | 0.46 | 0.09 | + +++ | 1.27 (1.17–1.38) | 1.19 × 10−8 | 1.28 (1.18–1.39) | 1.91 × 10−9 |
rs181176493 | 2:224157866_G/A | TRK-TTT15-1(pseudo)*, KCNE4† | 0.01 | 3.88 (2.33–6.47) | 1.98 × 10−7 | 0.80 | – | – | – | + ??? | 3.88 (2.33–6.47) | 1.98 × 10−7 | 3.62 (2.19–5.98) | 4.91 × 10−7 |
rs70962766 | 2:62406999_ CTTTTTTTTTTTT/C | RPSA26(pseudo)*, B3GNT2* | 0.99 | 0.2 (0.11–0.37) | 4.68 × 10−7 | 0.64 | – | – | – | − ??? | 0.2 (0.11–0.37) | 4.68 × 10−7 | 0.47 (0.29–0.75) | 0.0017 |
rs138181578 | 6:45725830_A/AT | LOC107986519†, CLIC5† | 0.99 | 0.18 (0.09–0.35) | 6.78 × 10−7 | 0.77 | – | – | – | − ??? | 0.18 (0.09–0.35) | 6.78 × 10−7 | 0.36 (0.22–0.60) | 8.33 × 10−5 |
rs10625784 | 11:106193897_T/TAAA | LOC643855*, AASDHPPT† | 0.99 | 0.23 (0.13–0.42) | 7.63 × 10−7 | 0.83 | – | – | – | − ??? | 0.23 (0.13–0.42) | 7.63 × 10−7 | 0.44 (0.28–0.70) | 0.00045 |
rs79237700 | 15:53741612_T/C | LOC105370826, WDR72* | 0.04 | 1.97 (1.51–2.55) | 3.86 × 10−7 | 0.75 | 237/632 | 0.17 | 0.79 | + −?? | 1.82 (1.42–2.33) | 2.23 × 10−6 | 1.76 (1.37–2.25) | 6.88 × 10−6 |
rs574480779 | 5:154390880_TA/T | KIF4B | 0.03 | 2.27 (1.64–3.15) | 9.36 × 10−7 | 0.69 | – | – | – | + ??? | 2.27 (1.64–3.15) | 9.36 × 10−7 | 2.14 (1.56–2.95) | 2.91 × 10−6 |
rs1344228 | 2:124286924_C/T | LOC100422580†, CNTNAP5‡ | 0.11 | 1.46 (1.26–1.69) | 5.64 × 10−7 | 1.00 | 434/3123 | 0.33 | 0.71 | + −++ | 1.33 (1.17–1.51) | 8.68 × 10−6 | 1.33 (1.17–1.50) | 8.30 × 10−6 |
rs6055069 | 20:134284_T/C | DEFB127 | 0.98 | 0.24 (0.15–0.38) | 2.35 × 10−9 | 0.62 | 322/1917 | 0.95 | 0.74 | − +?− | 0.38 (0.25–0.56) | 1.36 × 10−6 | 0.49 (0.35–0.70) | 9.80 × 10−5 |
rs2112481 | 5:125691632_T/G | GRAMD2B | 0.99 | 0.10 (0.04–0.23) | 6.98 × 10−8 | 0.63 | 434/3123 | 1 | 0.35 | − +−+ | 0.67 (0.43–1.01) | 0.058 | 0.73 (0.50–1.06) | 0.097 |
−, protection; ?, data not available; +, predisposition; Chr:Pos_REF/ALT, chromosome and base pair position, reference/alternative (=non-effect/effect) allele; Dir, effect direction (for effect i.e. alternative allele) in FinnDiane, SDCC, UK-ROI, and French; EAF, effect (alternative) allele frequency; Gene, closest gene(s) underlying or within the promoter region (5kbp upstream), or *within ±50kbp, †within ±250kbp, or ‡within ±500kbp; N, Ncases/controls in replication; OR (95% CI), odds ratio and 95% confidence interval; Power, statistical power to observe association with α = 0.05/5 = 0.01 significance level, based on discovery study EAF and 95% lower CI of OR, and 12.2%, 27.3%, or 14.4% CAD prevalence in corresponding replication cohort; RSQ, imputation r2 quality estimate.
NFinnDaine = 926/3777 in meta-analysis with DKD.
GWAS, replication and meta-analysis results for loci reaching P < 10−6 in the discovery GWAS
Discovery stage . | Replication . | Meta-analysis . | Meta-analysis with DKD adjustmenta . | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNP . | Chr:Pos_REF/ALT . | Gene . | EAF . | OR (95% CI) . | P-value . | RSQ . | N . | Power . | P-value . | Dir . | OR (95% CI) . | P-value . | OR (95% CI) . | P-value . |
rs1970112 | 9:22085598_T/C | CDKN2B-AS1 | 0.41 | 1.32 (1.2–1.46) | 1.50 × 10−8 | 0.98 | 434/3123 | 0.46 | 0.09 | + +++ | 1.27 (1.17–1.38) | 1.19 × 10−8 | 1.28 (1.18–1.39) | 1.91 × 10−9 |
rs181176493 | 2:224157866_G/A | TRK-TTT15-1(pseudo)*, KCNE4† | 0.01 | 3.88 (2.33–6.47) | 1.98 × 10−7 | 0.80 | – | – | – | + ??? | 3.88 (2.33–6.47) | 1.98 × 10−7 | 3.62 (2.19–5.98) | 4.91 × 10−7 |
rs70962766 | 2:62406999_ CTTTTTTTTTTTT/C | RPSA26(pseudo)*, B3GNT2* | 0.99 | 0.2 (0.11–0.37) | 4.68 × 10−7 | 0.64 | – | – | – | − ??? | 0.2 (0.11–0.37) | 4.68 × 10−7 | 0.47 (0.29–0.75) | 0.0017 |
rs138181578 | 6:45725830_A/AT | LOC107986519†, CLIC5† | 0.99 | 0.18 (0.09–0.35) | 6.78 × 10−7 | 0.77 | – | – | – | − ??? | 0.18 (0.09–0.35) | 6.78 × 10−7 | 0.36 (0.22–0.60) | 8.33 × 10−5 |
rs10625784 | 11:106193897_T/TAAA | LOC643855*, AASDHPPT† | 0.99 | 0.23 (0.13–0.42) | 7.63 × 10−7 | 0.83 | – | – | – | − ??? | 0.23 (0.13–0.42) | 7.63 × 10−7 | 0.44 (0.28–0.70) | 0.00045 |
rs79237700 | 15:53741612_T/C | LOC105370826, WDR72* | 0.04 | 1.97 (1.51–2.55) | 3.86 × 10−7 | 0.75 | 237/632 | 0.17 | 0.79 | + −?? | 1.82 (1.42–2.33) | 2.23 × 10−6 | 1.76 (1.37–2.25) | 6.88 × 10−6 |
rs574480779 | 5:154390880_TA/T | KIF4B | 0.03 | 2.27 (1.64–3.15) | 9.36 × 10−7 | 0.69 | – | – | – | + ??? | 2.27 (1.64–3.15) | 9.36 × 10−7 | 2.14 (1.56–2.95) | 2.91 × 10−6 |
rs1344228 | 2:124286924_C/T | LOC100422580†, CNTNAP5‡ | 0.11 | 1.46 (1.26–1.69) | 5.64 × 10−7 | 1.00 | 434/3123 | 0.33 | 0.71 | + −++ | 1.33 (1.17–1.51) | 8.68 × 10−6 | 1.33 (1.17–1.50) | 8.30 × 10−6 |
rs6055069 | 20:134284_T/C | DEFB127 | 0.98 | 0.24 (0.15–0.38) | 2.35 × 10−9 | 0.62 | 322/1917 | 0.95 | 0.74 | − +?− | 0.38 (0.25–0.56) | 1.36 × 10−6 | 0.49 (0.35–0.70) | 9.80 × 10−5 |
rs2112481 | 5:125691632_T/G | GRAMD2B | 0.99 | 0.10 (0.04–0.23) | 6.98 × 10−8 | 0.63 | 434/3123 | 1 | 0.35 | − +−+ | 0.67 (0.43–1.01) | 0.058 | 0.73 (0.50–1.06) | 0.097 |
Discovery stage . | Replication . | Meta-analysis . | Meta-analysis with DKD adjustmenta . | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNP . | Chr:Pos_REF/ALT . | Gene . | EAF . | OR (95% CI) . | P-value . | RSQ . | N . | Power . | P-value . | Dir . | OR (95% CI) . | P-value . | OR (95% CI) . | P-value . |
rs1970112 | 9:22085598_T/C | CDKN2B-AS1 | 0.41 | 1.32 (1.2–1.46) | 1.50 × 10−8 | 0.98 | 434/3123 | 0.46 | 0.09 | + +++ | 1.27 (1.17–1.38) | 1.19 × 10−8 | 1.28 (1.18–1.39) | 1.91 × 10−9 |
rs181176493 | 2:224157866_G/A | TRK-TTT15-1(pseudo)*, KCNE4† | 0.01 | 3.88 (2.33–6.47) | 1.98 × 10−7 | 0.80 | – | – | – | + ??? | 3.88 (2.33–6.47) | 1.98 × 10−7 | 3.62 (2.19–5.98) | 4.91 × 10−7 |
rs70962766 | 2:62406999_ CTTTTTTTTTTTT/C | RPSA26(pseudo)*, B3GNT2* | 0.99 | 0.2 (0.11–0.37) | 4.68 × 10−7 | 0.64 | – | – | – | − ??? | 0.2 (0.11–0.37) | 4.68 × 10−7 | 0.47 (0.29–0.75) | 0.0017 |
rs138181578 | 6:45725830_A/AT | LOC107986519†, CLIC5† | 0.99 | 0.18 (0.09–0.35) | 6.78 × 10−7 | 0.77 | – | – | – | − ??? | 0.18 (0.09–0.35) | 6.78 × 10−7 | 0.36 (0.22–0.60) | 8.33 × 10−5 |
rs10625784 | 11:106193897_T/TAAA | LOC643855*, AASDHPPT† | 0.99 | 0.23 (0.13–0.42) | 7.63 × 10−7 | 0.83 | – | – | – | − ??? | 0.23 (0.13–0.42) | 7.63 × 10−7 | 0.44 (0.28–0.70) | 0.00045 |
rs79237700 | 15:53741612_T/C | LOC105370826, WDR72* | 0.04 | 1.97 (1.51–2.55) | 3.86 × 10−7 | 0.75 | 237/632 | 0.17 | 0.79 | + −?? | 1.82 (1.42–2.33) | 2.23 × 10−6 | 1.76 (1.37–2.25) | 6.88 × 10−6 |
rs574480779 | 5:154390880_TA/T | KIF4B | 0.03 | 2.27 (1.64–3.15) | 9.36 × 10−7 | 0.69 | – | – | – | + ??? | 2.27 (1.64–3.15) | 9.36 × 10−7 | 2.14 (1.56–2.95) | 2.91 × 10−6 |
rs1344228 | 2:124286924_C/T | LOC100422580†, CNTNAP5‡ | 0.11 | 1.46 (1.26–1.69) | 5.64 × 10−7 | 1.00 | 434/3123 | 0.33 | 0.71 | + −++ | 1.33 (1.17–1.51) | 8.68 × 10−6 | 1.33 (1.17–1.50) | 8.30 × 10−6 |
rs6055069 | 20:134284_T/C | DEFB127 | 0.98 | 0.24 (0.15–0.38) | 2.35 × 10−9 | 0.62 | 322/1917 | 0.95 | 0.74 | − +?− | 0.38 (0.25–0.56) | 1.36 × 10−6 | 0.49 (0.35–0.70) | 9.80 × 10−5 |
rs2112481 | 5:125691632_T/G | GRAMD2B | 0.99 | 0.10 (0.04–0.23) | 6.98 × 10−8 | 0.63 | 434/3123 | 1 | 0.35 | − +−+ | 0.67 (0.43–1.01) | 0.058 | 0.73 (0.50–1.06) | 0.097 |
−, protection; ?, data not available; +, predisposition; Chr:Pos_REF/ALT, chromosome and base pair position, reference/alternative (=non-effect/effect) allele; Dir, effect direction (for effect i.e. alternative allele) in FinnDiane, SDCC, UK-ROI, and French; EAF, effect (alternative) allele frequency; Gene, closest gene(s) underlying or within the promoter region (5kbp upstream), or *within ±50kbp, †within ±250kbp, or ‡within ±500kbp; N, Ncases/controls in replication; OR (95% CI), odds ratio and 95% confidence interval; Power, statistical power to observe association with α = 0.05/5 = 0.01 significance level, based on discovery study EAF and 95% lower CI of OR, and 12.2%, 27.3%, or 14.4% CAD prevalence in corresponding replication cohort; RSQ, imputation r2 quality estimate.
NFinnDaine = 926/3777 in meta-analysis with DKD.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.